EN
HI
Medicamen Biotech Share price
MEDICAMEQ
244.55
0.80 (0.33%)NSE
BSE
Last updated on 21 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Medicamen Biotech share price chart
Medicamen Biotech Share Key Metrics
Volume
32783.00
Market Cap
331.68 CR
LTQ@LTP
1@244.55
ATP
246.13
Var Margin
22.88 %
Circuit Range
195.64-293.46
Delivery %
75.82 %
Value
80.69 L
ASM/GSM
No
Market Lot
1
Summary
MEDICAMEQ stock price is ₹244.55 as of 24 Aug, 2026. The stock intraday movement has stayed between ₹238.81 and ₹249.00, while Medicamen Biotech share price 52 week high low is ₹212.40 & ₹447.65.
In terms of trading activity, MEDICAMEQ share price has recorded a volume of 32,783 shares. The Medicamen Biotech has a market cap of ₹13562815. The stock’s Average Traded Price (ATP) stands at ₹246.13, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹244.55.
The Medicamen Biotech upper circuit limit is ₹293.46 & The Medicamen Biotech lower circuit limit is ₹195.64, with a Value of ₹80.69 L. The Delivery Percentage for the day is 75.82%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Medicamen Biotech Resistance and Support
Pivot 238.59
Resistance
First Resistance
249.57
Second Resistance
255.38
Third Resistance
266.36
Support
First Support
232.78
Second Support
221.8
Third Support
215.99
Medicamen Biotech Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
40.46%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0.02%
Domestic Institutional Investors
0.49%
Retail
59.03%
Others
0%
Total Promoters
MAR '25
43.16%
JUN '25
40.46%
SEP '25
40.46%
DEC '25
40.46%
Medicamen Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-27 | Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-26 | Preferential issue of shares |
| 2025-02-11 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-26 | 2025-09-26 | View More |
Medicamen Biotech News
Medicamen Biotech Ltd-$ - 531146 - Intimation Of Book Clsoure And Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligationa And Disclosure Requirements) Regulation 2015
Medicamen Biotech has set September 19, 2026, as the Record Date for its final dividend for the financial year ended March 31, 2026. This determines eligible shareholders for the dividend, pending approval at the 33rd AGM.
Aug 18 2026 13:26:05
Medicamen Biotech Ltd-$ - 531146 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 30 June 2026.
Medicamen Biotech's board will hold a meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with draft annual and cost audit reports.
Aug 07 2026 14:57:51
Medicamen Biotech Management
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Independent & Non Executive Director |
Medicamen Biotech Similar Stocks
Medicamen Biotech FAQs
The Buying Price of Medicamen Biotech share is 244.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 30.82. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Medicamen Biotech shares is 1.23. Useful to assess the stock's value relative to its book value.
To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Medicamen Biotech is 331.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Medicamen Biotech share price is 447.65 & 212.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Medicamen Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in MEDICAMEQ
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC